Peptide–drug conjugate-based novel molecular drug delivery system in cancer

药品 药物输送 结合 药理学 化学 医学 靶向给药 生物化学 数学 数学分析 有机化学
作者
Yishen Zhu,Kexing Tang,Jiayi Lv
出处
期刊:Trends in Pharmacological Sciences [Elsevier BV]
卷期号:42 (10): 857-869 被引量:107
标识
DOI:10.1016/j.tips.2021.07.001
摘要

A single peptide–drug conjugate molecule achieves multiple biological functions, which is proposed as a novel drug delivery system, the molecular drug delivery system. Recently, peptide–drug conjugates have been introduced as potential diagnostics and anticancer drugs in the clinic. Aminopeptidase N, integrins, the somatostatin receptor, and several other receptors are major molecular targeting receptors for current peptide–drug conjugate-based molecular drug delivery systems. Solving the problem of oral administration will greatly promote the development of peptide–drug conjugate molecular drug delivery systems. Drug delivery systems are generally believed to comprise drugs and excipients. A peptide–drug conjugate is a single molecule that can simultaneously play multiple roles in a drug delivery system, such as in vivo drug distribution, targeted release, and bioactivity functions. This molecule can be regarded as an integrated drug delivery system, so it is called a molecular drug delivery system. In the context of cancer therapy, a peptide–drug conjugate comprises a tumor-targeting peptide, a payload, and a linker. Tumor-targeting peptides specifically identify membrane receptors on tumor cells, improve drug-targeted therapeutic effects, and reduce toxic and side effects. Payloads with bioactive functions connect to tumor-targeting peptides through linkers. In this review, we explored ongoing clinical work on peptide–drug conjugates targeting various receptors. We discuss the binding mechanisms of tumor-targeting peptides and related receptors, as well as the limiting factors for peptide–drug conjugate-based molecular drug delivery systems. Drug delivery systems are generally believed to comprise drugs and excipients. A peptide–drug conjugate is a single molecule that can simultaneously play multiple roles in a drug delivery system, such as in vivo drug distribution, targeted release, and bioactivity functions. This molecule can be regarded as an integrated drug delivery system, so it is called a molecular drug delivery system. In the context of cancer therapy, a peptide–drug conjugate comprises a tumor-targeting peptide, a payload, and a linker. Tumor-targeting peptides specifically identify membrane receptors on tumor cells, improve drug-targeted therapeutic effects, and reduce toxic and side effects. Payloads with bioactive functions connect to tumor-targeting peptides through linkers. In this review, we explored ongoing clinical work on peptide–drug conjugates targeting various receptors. We discuss the binding mechanisms of tumor-targeting peptides and related receptors, as well as the limiting factors for peptide–drug conjugate-based molecular drug delivery systems. a chemotherapy medication used to treat chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and non-Hodgkin lymphoma. the rate of application of a dose, which means quantity (in units of energy/mass) in the fields of nutrition, and medicine, although in common and imprecise usage the words are sometimes used synonymously. formulation technologies for transporting active pharmaceutical ingredients in the body as needed to safely achieve the desired therapeutic or diagnostic effects. engineered technologies that use nanoscale particles for the targeted delivery and controlled release of active pharmaceutical ingredients. gives companies researching cures for rare diseases a 7-year window of tax reductions and the exclusive right to develop a cure for a specific condition. active pharmaceutical ingredients, which can be effectively used for diagnosis/treatment in patients. a small, protein-like chain designed to mimic a peptide. tomography in which a computer-generated image of a biological activity in the body is produced through the detection of gamma-rays that are emitted when introduced radionuclides decay and release positrons. a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G protein-coupled somatostatin receptors and inhibition of the release of numerous secondary hormones. a short peptide, typically in an α-helical conformation, that is constrained by a synthetic brace as a staple.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xie69完成签到,获得积分10
刚刚
Yuan发布了新的文献求助10
刚刚
1秒前
ssssssssci完成签到,获得积分10
1秒前
春眠不觉小小酥完成签到,获得积分10
1秒前
多喝水完成签到 ,获得积分10
1秒前
1秒前
Paperduoduo完成签到,获得积分10
1秒前
HuiJN完成签到 ,获得积分10
2秒前
2秒前
ning完成签到,获得积分10
2秒前
2秒前
善学以致用应助苏卿采纳,获得10
3秒前
KKK完成签到,获得积分10
3秒前
3秒前
zhuzhu发布了新的文献求助10
4秒前
yeeeee完成签到 ,获得积分10
4秒前
5秒前
5秒前
研友_Y59785应助科研通管家采纳,获得10
5秒前
5秒前
5秒前
热固性塑料完成签到,获得积分10
6秒前
王强完成签到,获得积分10
6秒前
阔达磬发布了新的文献求助10
7秒前
左丘以云发布了新的文献求助10
7秒前
嘟呜发布了新的文献求助10
8秒前
豆芽完成签到,获得积分10
8秒前
pakiorder完成签到,获得积分10
9秒前
jiabaoyu发布了新的文献求助10
9秒前
xiaojinyu完成签到 ,获得积分10
9秒前
小熊不熊完成签到,获得积分10
9秒前
是谁还没睡完成签到 ,获得积分10
10秒前
夏目由美完成签到 ,获得积分10
11秒前
猫好好完成签到,获得积分10
12秒前
迷路的游侠完成签到,获得积分10
12秒前
等待安柏完成签到,获得积分20
12秒前
illusion完成签到,获得积分10
12秒前
CDY完成签到,获得积分10
13秒前
华仔应助T拐拐采纳,获得10
13秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Social Research Methods (4th Edition) by Maggie Walter (2019) 2390
A new approach to the extrapolation of accelerated life test data 1000
北师大毕业论文 基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 390
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Robot-supported joining of reinforcement textiles with one-sided sewing heads 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4009254
求助须知:如何正确求助?哪些是违规求助? 3549107
关于积分的说明 11300780
捐赠科研通 3283530
什么是DOI,文献DOI怎么找? 1810370
邀请新用户注册赠送积分活动 886168
科研通“疑难数据库(出版商)”最低求助积分说明 811267